- Release Date: 27/02/23 16:11
- Summary: 2022 Full Year Results Presentation
- Price Sensitive: Yes
- Download Document 3.47MB
- Forums
- ASX - By Stock
- TLX
- Ann: 2022 Full Year Results Presentation
TLX
telix pharmaceuticals limited
Add to My Watchlist
1.44%
!
$24.30

Ann: 2022 Full Year Results Presentation
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$24.30 |
Change
0.345(1.44%) |
Mkt cap ! $8.221B |
Open | High | Low | Value | Volume |
$24.20 | $24.43 | $23.92 | $15.26M | 630.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 347 | $24.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$24.30 | 5263 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 336 | 24.290 |
14 | 1367 | 24.280 |
10 | 929 | 24.270 |
16 | 1145 | 24.260 |
10 | 876 | 24.250 |
Price($) | Vol. | No. |
---|---|---|
24.300 | 5233 | 26 |
24.310 | 969 | 9 |
24.320 | 1014 | 11 |
24.330 | 713 | 4 |
24.340 | 614 | 4 |
Last trade - 14.05pm 04/07/2025 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online